DDB2 and neoplasm: In addition, Gaigai W et al. found that DDB2 is an upstream positive regulator of the TGF-β pathway, stabilizing p-SMAD2 by inhibiting NEDD4L, thereby enhancing the tumor suppression function of TGF-β (Gaigai et al., 2024).